SCHEMBL14898461

SCHEMBL14898461

CC1CN(CC2CN(S(=O)(=O)c3cccs3)CCN2c2ccc(C(C)(C)O)cc2)CCO1

nearest known ligand 0.66

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 8/20 0.66
GCK P35557 12/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12089601 1.00 GCKR (0.66) GCKRGCK
SCHEMBL12089164 1.00 GCKR (0.66) GCKRGCK
SCHEMBL12089604 1.00 GCKR (0.66) GCKRGCK
SCHEMBL12089001 1.00 GCKR (0.66) GCKRGCK
SCHEMBL12089162 1.00 GCKR (0.66) GCKRGCK
SCHEMBL12078728 0.93 GCK (0.74) GCKRGCK
SCHEMBL17767 0.93 GCK (0.74) GCKRGCK
SCHEMBL12078625 0.93 GCK (0.74) GCKRGCK
SCHEMBL18104 0.93 GCK (0.74) GCKRGCK
SCHEMBL18106 0.93 GCK (0.74) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431563-B2 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes AMGEN INC. (US) 2013-04-30 US disclosed